loading
Schlusskurs vom Vortag:
$7.86
Offen:
$7.77
24-Stunden-Volumen:
157.78K
Relative Volume:
1.06
Marktkapitalisierung:
$163.60M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-22.38M
KGV:
-5.5248
EPS:
-1.41
Netto-Cashflow:
$-15.54M
1W Leistung:
-1.13%
1M Leistung:
-1.50%
6M Leistung:
+20.00%
1J Leistung:
+13.09%
1-Tages-Spanne:
Value
$7.77
$8.11
1-Wochen-Bereich:
Value
$7.70
$8.21
52-Wochen-Spanne:
Value
$4.44
$11.80

Nuvectis Pharma Inc Stock (NVCT) Company Profile

Name
Firmenname
Nuvectis Pharma Inc
Name
Telefon
360-837-7232
Name
Adresse
1 BRIDGE PLAZA, SUITE 275, FORT LEE
Name
Mitarbeiter
13
Name
Twitter
Name
Nächster Verdiensttermin
2024-08-07
Name
Neueste SEC-Einreichungen
Name
NVCT's Discussions on Twitter

Vergleichen Sie NVCT mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Biotechnology icon
NVCT
Nuvectis Pharma Inc
7.83 168.82M 0 -22.38M -15.54M -1.41
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
473.87 120.73B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
569.74 60.56B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
329.03 42.41B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
581.51 34.96B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
294.51 31.99B 3.81B -644.79M -669.77M -6.24

Nuvectis Pharma Inc Stock (NVCT) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2025-04-02 Eingeleitet Maxim Group Buy
2025-03-17 Eingeleitet Laidlaw Buy
2022-07-13 Eingeleitet Ladenburg Thalmann Buy

Nuvectis Pharma Inc Aktie (NVCT) Neueste Nachrichten

pulisher
Jul 23, 2025

Nuvectis Pharma Inc. Stock Analysis and ForecastHigh-yield investments - Autocar Professional

Jul 23, 2025
pulisher
Jul 23, 2025

What analysts say about Nuvectis Pharma Inc. stockDynamic profit opportunities - Autocar Professional

Jul 23, 2025
pulisher
Jul 23, 2025

What drives Nuvectis Pharma Inc. stock priceTriple-digit return opportunities - Autocar Professional

Jul 23, 2025
pulisher
Jul 22, 2025

Is Nuvectis Pharma Inc. a good long term investmentRemarkable growth - jammulinksnews.com

Jul 22, 2025
pulisher
Jul 22, 2025

(NVCT) On The My Stocks Page - news.stocktradersdaily.com

Jul 22, 2025
pulisher
Jul 21, 2025

Nuvectis Pharma, Inc. Reports First Quarter 2025 Financial Results and Business Highlights - Yahoo.co

Jul 21, 2025
pulisher
Jul 15, 2025

How Nuvectis Pharma Inc. stock performs during market volatilityFree Growth Investment Group - Newser

Jul 15, 2025
pulisher
Jul 15, 2025

What makes Nuvectis Pharma Inc. stock price move sharplyHigh Confidence Trade Setups - Newser

Jul 15, 2025
pulisher
Jul 15, 2025

Why Nuvectis Pharma Inc. stock attracts strong analyst attentionProfitable Yet Secure Picks - Newser

Jul 15, 2025
pulisher
Jul 12, 2025

When (NVCT) Moves Investors should Listen - news.stocktradersdaily.com

Jul 12, 2025
pulisher
Jul 08, 2025

Nuvectis reports positive drug interaction study for cancer drug NXP900 By Investing.com - Investing.com Nigeria

Jul 08, 2025
pulisher
Jul 08, 2025

Nuvectis Pharma, Inc. Announces Successful Completion of A Drug-Drug Interaction Study in Healthy Volunteers - MarketScreener

Jul 08, 2025
pulisher
Jul 08, 2025

Nuvectis Pharma Announces Successful Completion of a Drug-Drug Interaction Study in Healthy Volunteers Supporting NXP900's Potential as a Combination Partner with Leading Therapies - GlobeNewswire

Jul 08, 2025
pulisher
Jul 02, 2025

Nuvectis Pharma, Inc. (NASDAQ:NVCT) Shares Purchased by Oppenheimer & Co. Inc. - Defense World

Jul 02, 2025
pulisher
Jul 01, 2025

(NVCT) Technical Pivots with Risk Controls - news.stocktradersdaily.com

Jul 01, 2025
pulisher
Jun 30, 2025

Nuvectis Pharma, Inc.(NasdaqCM: NVCT) added to Russell 3000 Index - MarketScreener

Jun 30, 2025
pulisher
Jun 29, 2025

Nuvectis Pharma (NASDAQ:NVCT) Lowered to “Sell” Rating by Wall Street Zen - Defense World

Jun 29, 2025
pulisher
Jun 25, 2025

Is Nuvectis Pharma, Inc. technically bullish or bearish? - MarketsMojo

Jun 25, 2025
pulisher
Jun 21, 2025

(NVCT) Proactive Strategies - news.stocktradersdaily.com

Jun 21, 2025
pulisher
Jun 20, 2025

Silicon Valley - FinancialContent

Jun 20, 2025
pulisher
Jun 18, 2025

Nuvectis Pharma: Still Interesting, But Still Too Risky To Jump In - Seeking Alpha

Jun 18, 2025
pulisher
Jun 18, 2025

Insiders of Nuvectis Pharma, Inc. (NASDAQ:NVCT) must be disappointed as stock fell 10% after recent purchases - Yahoo Finance

Jun 18, 2025
pulisher
Jun 18, 2025

Insider Stock Buying Of Nuvectis Pharma Delivers Return On US$2.19m Investment - simplywall.st

Jun 18, 2025
pulisher
Jun 13, 2025

Nuvectis Pharma Approves Proposals at Annual Meeting - TipRanks

Jun 13, 2025
pulisher
Jun 13, 2025

Nuvectis Pharma, Inc. (NASDAQ:NVCT) Shares Sold by Two Sigma Investments LP - Defense World

Jun 13, 2025
pulisher
Jun 13, 2025

Millennium Management LLC Reduces Holdings in Nuvectis Pharma, Inc. (NASDAQ:NVCT) - Defense World

Jun 13, 2025
pulisher
Jun 10, 2025

(NVCT) Investment Analysis - news.stocktradersdaily.com

Jun 10, 2025
pulisher
Jun 10, 2025

Squarepoint Ops LLC Invests $103,000 in Nuvectis Pharma, Inc. (NASDAQ:NVCT) - Defense World

Jun 10, 2025
pulisher
Jun 09, 2025

Does Nuvectis Pharma (NVCT) Have the Potential to Rally 108.79% as Wall Street Analysts Expect? - MSN

Jun 09, 2025
pulisher
Jun 04, 2025

Nuvectis Pharma, Inc. (NASDAQ:NVCT) Shares Bought by Northern Trust Corp - Defense World

Jun 04, 2025
pulisher
May 20, 2025

Cubist Systematic Strategies LLC Invests $34,000 in Nuvectis Pharma, Inc. (NASDAQ:NVCT) - Defense World

May 20, 2025
pulisher
May 16, 2025

Nuvectis Pharma to Present at the H.C. Wainwright BioConnect Investor Conference - GlobeNewswire

May 16, 2025
pulisher
May 12, 2025

Nuvectis pharma investor Charles Mosseri Marlio buys $247k in stock By Investing.com - Investing.com India

May 12, 2025

Finanzdaten der Nuvectis Pharma Inc-Aktie (NVCT)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading

Nuvectis Pharma Inc-Aktie (NVCT) Insiderhandel

Insiderhandel Beziehung Datum Transaktion Kosten #Aktien Wert ($) #Aktien Gesamt
Mosseri Marlio Charles
10% Owner
Jun 18 '25
Buy
8.05
28,043
225,746
2,976,203
Mosseri Marlio Charles
10% Owner
Jun 17 '25
Buy
8.11
5,399
43,786
2,948,160
Mosseri Marlio Charles
10% Owner
May 12 '25
Buy
8.11
21,167
171,664
2,942,761
Mosseri Marlio Charles
10% Owner
May 06 '25
Buy
8.59
12,444
106,955
2,896,565
Mosseri Marlio Charles
10% Owner
May 07 '25
Buy
8.59
12,317
105,770
2,908,882
Mosseri Marlio Charles
10% Owner
May 08 '25
Buy
8.65
2,650
22,922
2,911,532
Mosseri Marlio Charles
10% Owner
Feb 07 '25
Buy
5.00
240,000
1,200,000
2,884,121
BENTSUR RON
Chairman & CEO
Dec 24 '24
Buy
4.65
4,500
20,925
3,270,924
Mosseri Marlio Charles
10% Owner
Dec 13 '24
Buy
4.70
17,000
79,900
2,612,000
Poradosu Enrique
Chief Science & Business Off
Nov 19 '24
Buy
4.99
2,000
9,980
1,506,319
$23.55
price up icon 3.06%
$36.26
price up icon 0.64%
$102.96
price down icon 0.51%
$27.70
price down icon 0.89%
$114.09
price down icon 0.58%
biotechnology ONC
$294.60
price down icon 0.15%
Kapitalisierung:     |  Volumen (24h):